Rational selection of structurally diverse natural product scaffolds with favorable ADME properties for drug discovery

被引:0
作者
D.S Samiulla
V. V. Vaidyanathan
P. C. Arun
G. Balan
M. Blaze
S Bondre
G. Chandrasekhar
A. Gadakh
R. Kumar
G. Kharvi
H.-O. Kim
S. Kumar
J. A. Malikayil
M. Moger
M. K. Mone
P Nagarjuna
C. Ogbu
D. Pendhalkar
A. V. S. Raja Rao
G. Venkateshwar Rao
V. K. Sarma
S. Shaik
G. V. R. Sharma
S. Singh
C. Sreedhar
R. Sonawane
U. Timmanna
L. W. Hardy
机构
[1] Electronic City Phase 2,Aurigene Discovery Technologies, Ltd.
[2] 99 Hayden Avenue,Aurigene Discovery Technologies, Inc.
[3] Lexington,undefined
来源
Molecular Diversity | 2005年 / 9卷
关键词
computational design; early ADME; lead-like; metabolic stability; natural products; permeability; scaffold;
D O I
暂无
中图分类号
学科分类号
摘要
Natural product analogs are significant sources for therapeutic agents. To capitalize efficiently on the effective features of naturally occurring substances, a natural product-based library production platform has been devised at Aurigene for drug lead discovery. This approach combines the attractive biological and physicochemical properties of natural product scaffolds, provided by eons of natural selection, with the chemical diversity available from parallel synthetic methods. Virtual property analysis, using computational methods described here, guides the selection of a set of natural product scaffolds that are both structurally diverse and likely to have favorable pharmacokinetic properties. The experimental characterization of several in vitro ADME properties of twenty of these scaffolds, and of a small set of designed congeners based upon one scaffold, is also described. These data confirm that most of the scaffolds and the designed library members have properties favorable to their utilization for creating libraries of lead-like molecules.
引用
收藏
页码:131 / 139
页数:8
相关论文
共 80 条
  • [1] Newman D.J.(2003)Natural products as sources of new drugs over the period 1981–2002 J. Nat. Prod. 66 1022-1037
  • [2] Cragg G.M.(2003)Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry J. Chem. Inf. Comput. Sci. 43 218-227
  • [3] Snader K.M.(1999)Statistical investigation into the structural complementarity of natural products and synthetic compounds Angew. Chem. Int. 38 643-647
  • [4] Feher M.(2003)Rediscovering natural products Chem. Eng. News 81 77-91
  • [5] Schmidt J.M.(2003)Betting on natural products for cures Chem. Eng. News 81 93-103
  • [6] Henkel T.(2003)Moving beyond natural products Chem. Eng. News 81 104-107
  • [7] Brunne R.M.(2003)Gugulipid: A natural cholesterol-lowering agent Annu. Rev. Nutr. 23 303-313
  • [8] Muller H.(2002)A natural product that lowers cholesterol as an antagonist ligand for FXR Science 296 1703-1706
  • [9] Reichel F.(2003)ADMET in silico modelling: Towards prediction paradise? Nat. Rev. Drug. Discov. 2 192-204
  • [10] Rouhi A.M.(1997)Managing the drug discovery/development interface Drug Discov. Today 2 436-444